Clinical Trial Update: Pulmonary Hypertension and Imatinib

View source ↗

Summary

A completed clinical trial evaluating imatinib for pulmonary arterial hypertension, sponsored by The Cleveland Clinic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Imatinib (Gleevec) (imatinib)

Snippet

Sponsor: The Cleveland Clinic | Conditions: PAH | Status: COMPLETED